Professional Ethics in Pharmacy: Exploring Contemporary Challenges and Future Directions

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 31 July 2024 | Viewed by 2533

Special Issue Editor


E-Mail Website
Guest Editor
Associate Professor, Faculty of Medicine and Health, Sydney, NSW 2006, Australia
Interests: ethics in pharmacy; end of life decision-making; hospital pharmacy; opioid substitution treatment [OST] services and harm minimization in pharmacy; cultural competence and health literacy in pharmacy; impairment in pharmacy; sport pharmacy; complementary medicines in pharmacy; prescribing in pharmacy

Special Issue Information

Dear Colleagues,

Pharmacists today are practising in a vastly different ecosystem to traditional models of practice and accepted norms of practice. Fast-tracked technological and healthcare advancements are emerging around the world with immense impact on healthcare delivery, including pharmacy, in the context of patient-centred care. No doubt the pandemic has also had impact on new emerging roles in pharmacy in many countries, such as vaccinating and rescheduling of many prescription medicines to “pharmacist-only” supply.

With pharmacists’ roles expanding, increased utility of artificial intelligence, and professional responsibilities are evolving. Ethical norms of practice are also expanding to encompass change and broader scope of practice. There is intense pressure on the profession to rise to the occasion to serve with integrity and enhance trust of the public. Ethical sensitivity and awareness of expectations of the public are therefore ever more important to the profession.

I invite you to share your thoughts and/or research on contemporary professional ethics in practice to this Special Edition of the Pharmacy Journal, entitled: Professional Ethics in Pharmacy: Exploring Contemporary Challenges and Future Directions of the Profession of Pharmacy.

Dr. Betty Bouad Chaar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • contemporary challenges in pharmacy practice
  • professional ethics in pharmacy
  • ethics and law in pharmacy
  • patient centred care
  • public trust in pharmacists
  • implicit bias in pharmacy practice
  • expanded roles in pharmacy
  • vaccination in pharmacy
  • pharmacists’ prescribing
  • AI in pharmacy
  • pharmacogenomics in pharmacy
  • conscientious objection in pharmacy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 615 KiB  
Article
Pharmacists’ Attitudes towards Medically Assisted Dying
by Lun Shen Wong, Shane L. Scahill, Emma Barton, Bert Van der Werf, Jessica Boey and Sanyogita (Sanya) Ram
Pharmacy 2024, 12(2), 40; https://doi.org/10.3390/pharmacy12020040 - 20 Feb 2024
Viewed by 1342
Abstract
Aims: We aimed to explore pharmacists’ attitudes and support toward medically assisted dying (MaiD) through the End of Life Choice Act 2019 (EOLC), their willingness to provide services in this area of practice, and the influences on their decisions. Methods: The study was [...] Read more.
Aims: We aimed to explore pharmacists’ attitudes and support toward medically assisted dying (MaiD) through the End of Life Choice Act 2019 (EOLC), their willingness to provide services in this area of practice, and the influences on their decisions. Methods: The study was conducted via an anonymous, online QualtricsTM survey of pharmacists. Registered New Zealand pharmacists who agreed to receive surveys from the two Schools of Pharmacy as part of their Annual Practicing Certificate renewal were invited to participate through an email with a Qualtrics URL link. The survey contained questions regarding demographics, awareness, knowledge, support for, and attitudes and willingness to participate. Results: Of the 335 responses received, 289 were valid and included in the analysis. Most participants supported legally assisted medical dying (58%), almost a third of participants did not support it (29%), and 13% of respondents were unsure. The five primary considerations that participants perceived to be beneficial included support from legislation, respect for patient autonomy, discussions around morality, ending suffering, and preserving dignity. The main concerns were legal, personal bias, palliation, stigmatisation, and vulnerability. Conclusions: The influences on the decision by pharmacists to support and willingness to participate in the provision of services consistent with the EOLC are complex and multifactorial. Diverse factors may influence attitudes, of which religion is the most significant factor in not supporting the Act or willingness to participate. Clarity and standardised guidance to ensure that assisted dying queries are appropriately managed in practice would help to address any potential access issues. Full article
Show Figures

Figure 1

Back to TopTop